Nasal high flow in patients with exacerbation COPD and/or pneumonia on the lungward

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24305

Enrollment

210

Registered

2019-11-26

Start date

2019-12-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD and pneumonia

Interventions

Patients will be randomized into 2 groups: the standard care group will receive oxygen therapy by the regular oxygen application. The intervention group will receive oxygen by the Nasal high flow.

Eligibility

Inclusion criteria

Inclusion criteria: Exacerbation COPD and/or pneumonia using a minimal of 1 liter oxygen/minute

Exclusion criteria

Exclusion criteria: - Indication voor NPPV - Pneumothorax - Delirium - ILD patients - Patients post lungtransplantation - Astma patients without persisting obstruction - Patient using Bi-pap or C-pap at home - Patients who are not able to read and speak Dutch

Design outcomes

Primary

Measure	Time frame
Primaire parameter is comfort. we ask patients to complete CCQ daily during admittion	—

Secondary

Measure	Time frame
Besides the primaire parameter, there will also measurements to investigate cough, dyspnea, oxygenation, respiration, heartfrequency, viscocity of the mucus and duration of admittion	—

Contacts

Public ContactLian Trapman

st Antonius ziekenhuis

l.trapman@antoniusziekenhuis.nl088 320 1545

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)